Skip to main content

Table 1 Characteristics of patients during the hospitalization for Covid-19

From: Residual respiratory impairment after COVID-19 pneumonia

  Available observations N = 87
Age, years   58 (13)
Male, n (%)   58 (67)
BMI (kg/m2)   26.7 (4.4)
p/F worst 76 281 (150)*
Hospitalization time (days) 86 13 (10)*
Day from discharge (days) 85 35 (21)*
Smoking history, n (%) 85  
 Never smoker   33 (39)
 Smoker   4 (5)
 Former smoker   48 (56)
Pulmonary disease history, n (%) 86  
 COPD   3 (4)
 Asthma   9 (11)
Radiology (chest XR or CT), n (%) 86  
 Chest CT performed   51 (59)
 Unilateral involvement   16 (19)
 Bilateral involvement   70 (81)
Antiviral therapy, n (%) 86  
 Lopinavir/Ritonavir   37 (43)
 Darunavir/Ritonavir   53 (62)
Anti-IL-6, n (%) 86 31 (36)
Enoxaparin, n (%) 86 42 (49)
Azithromycin, n (%) 86 41 (48)
Hydroxychloroquine, n (%) 86 81 (94)
Corticosteroids, n (%) 86 6 (7)
Respiratory support, n (%) 86  
 Ventimask   56 (65)
 HFNC   9 (11)
 NIV or CPAP   13 (15)
 Orotracheal Intubation   6 (7)
ICU admission, n (%) 86 15 (17)
FVC 83  
 Litres   3.9 (1.1)
 % predicted   104.6 (18.5)
FEV-1 83  
 Litres   3.1 (0.9)
 % predicted   102.8 (16.0)
FEV-1/FVC 83  
 % predicted   79.6 (5.8)
TLC 82  
 Litres   5.7 (1.3)
 % predicted   89.6 (14.6)
DLco 83  
 Litres   21.2 (6.8)
 % predicted   77.2 (16.5)
RV 82  
 Litres   1.58 (0.47)*
 % predicted   74.8 (18.1)
RC/TLC 82  
 Ratio   30 (10)*
 % predicted   79.0 (13.0)
ABG 84  
 pO2 (mmHg)   91.4 (8.0)
 pCO2 (mmHg)   38.8 (3.1)
 pH   7.42 (0.02)*
 d(A-a) (mmHg)   13.0 (7.5)
6MWT 82  
 SpO2 basal   97 (2)*
 SpO2 nadir   95 (4)*
 Meters   500 (88)*
  1. Categorical data are presented as counts (%). Continuous data are presented as means with standard deviation (SD) or medians with interquartile range (IQR) for non-normally distributed variables (indicated with *). BMI: Body Mass Index; ICU: Intensive Care Unit; COPD: Chronic Obstructive Pulmonary Disease; IL-6: Interleukin; HFNC: High Flow Nasal Cannula; NIV: Non-Invasive Ventilation; CPAP: Continue Positive Airway Pressure